MD SIMULATIONS OF DESIGNED HIV INHIBITORS
MD SIMULATIONS OF DESIGNED HIV INHIBITORS
批准号:
8364306
负责人:
CHRISTOPHER ASHMAN
金额:
$0.2万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-09-15 至 2013-07-31
关键词:
Active SitesAlgorithmsBehaviorBiomedical ResearchCharacteristicsDrug resistanceEducational process of instructingEnzyme InhibitionEnzymesFullerenesFundingGrantHIVHIV ProteaseHIV-1High Performance ComputingHydrocarbonsIndividualInvestigationLeadLearningLigandsMolecularMutateNational Center for Research ResourcesNaturePeptide HydrolasesPharmaceutical PreparationsPrincipal InvestigatorPropertyProtease InhibitorPublishingReportingResearchResearch InfrastructureResourcesRunningSamplingShapesSolubilitySourceSurfaceTestingTimeUnited States National Institutes of HealthViralViral Load resultVirusWaterWorkaqueousbasecomputer studiescostdesigninhibitor/antagonistinterestnovelsimulation
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources
provided by a Center grant funded by NIH/NCRR. Primary support for the subproject
and the subproject's principal investigator may have been provided by other sources,
including other NIH sources. The Total Cost listed for the subproject likely
represents the estimated amount of Center infrastructure utilized by the subproject,
not direct funding provided by the NCRR grant to the subproject or subproject staff.
The HIV-1 protease is a basket-shaped viral enzyme that participates in the maturation of the virus. Inhibition of this enzyme reduces the viral load in infected individuals. While several drugs are currently available that inhibit the function of the HIV protease, the need to design and develop new, novel drugs is imperative as the protease continues to rapidly mutate into drug-resistant forms. In the early 1990s Friedman and co-workers published two reports describing fullerene and fullerene derivatives (buckyballs) as inhibitors of HIV-1 protease as they are precisely the right size and shape to fit into and inhibit the active site. Unfortunately, this work did not lead to viable drugs as the aqueous solubility characteristics of the hydrocarbon-based buckyballs proved to be an insurmountable challenge. Recently we have published a computational study of the molecular behavior of an important class of new polyhedral molecules with different hydrophobic/hydrophilic properties. While studying these molecules we realized that their size and shape is quite comparable to C60 while the nature of their bonds allows them to be much more water soluble. We are interested in performing a computational investigation of the feasibility of using these molecules as HIV-1 protease inhibitors. Previously, we have performed MD simulations of the HIV protease sans any ligands; with C60; and in complexation with our molecules, using stochastic dynamics as implemented in MacroModel (serial) on the OPLS2005/GBSA(water) surface. We would like to verify our results using a different force field and sampling algorithm and so we have been teaching ourselves to properly use the AMBER and Desmond simulation packages. We are requesting 30,0000 units in order to run AMBER and Desmond on multiple processors shortening the testing and learning times.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MD SIMULATIONS OF DESIGNED HIV INHIBITORS
-
批准号:8171922
-
项目类别:
-
资助金额:$0.11万
-
财政年份:2010
-
负责人:CHRISTOPHER ASHMAN
-
依托单位:
海外基金